Latest Stock Split Details
Key information about Zelira Therapeutics Limited's most recent stock split
Split Date: 2022-04-14
Split Ratio: 1:175
Price Before Split: $0.00
Price After Split: $0.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 175.00 times fewer shares (a 1:175 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Zelira Therapeutics Limited's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-04-14 | 1:175 | Yes | $0.00 | $0.00 |
About Zelira Therapeutics Limited
Company overview and industry information
Zelira Therapeutics Limited (ZLDAF) operates in the Biotechnology industry. The recent 1-for-175 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Zelira Therapeutics Limited Summary